Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Phase 2    source : Www.alnylam.com    save search
New Results from Phase 1 Study of Cemdisiran + Pozelimab Presented at ASH Annual Meeting 2021
Published: 2021-12-14 (Crawled : 03:00) - alnylam.com
ALNY | $144.315 -0.58% -0.59% 700K twitter stocktwits trandingview |
Health Technology
 | | O: 6.02% H: 2.03% C: -0.29%
phase 1 results phase 2 phase 3
Complete Results from Phase 1/2 Study of Lumasiran (OXLUMO®) Published in Clinical Journal of the American Society of Nephrology
Published: 2021-05-15 (Crawled : 04:20) - alnylam.com
ALNY | $144.315 -0.58% -0.59% 700K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
phase 1 results phase 3 phase 2
Gainers vs Losers
67% 33%

Top 10 Gainers
GBR | $1.42 31.48% 11.27% 990K twitter stocktwits trandingview |
Energy Minerals
KUKE | $2.88 2.49% 7.64% 360K twitter stocktwits trandingview |

MPLN | $0.6502 -11.74% 4.51% 2.2M twitter stocktwits trandingview |
Finance
CXM 4 | $11.34 -0.44% 4.27% 1.7M twitter stocktwits trandingview |
Information
PVL 4 | $1.47 -0.68% 4.08% 77K twitter stocktwits trandingview |
Energy Minerals
RNR 4 | $224.74 0.85% 3.52% 310K twitter stocktwits trandingview |
Finance
PZG | $0.4431 0.48% 2.91% 150K twitter stocktwits trandingview |
Non-Energy Minerals
LEV | $0.972 0.73% 2.88% 570K twitter stocktwits trandingview |
Manufacturing
DBRG | $17.3 0.06% 1.97% 1.2M twitter stocktwits trandingview |
Finance and Insurance
OSK 4 | $117.72 0.05% 1.96% 370K twitter stocktwits trandingview |
Producer Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.